|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.525 USD | +2.01% |
|
-1.61% | -17.12% |
| May. 13 | TD Cowen Starts Biodesix With Buy Rating, $2.80 Price Target | MT |
| May. 08 | Transcript : Biodesix, Inc., Q1 2024 Earnings Call, May 08, 2024 |
Biodesix, Inc. provided revenue guidance for the year 2022. The company anticipated generating between $37.5 million to $39.5 million in total revenue in 2022.
| 1st Jan change | Capi. | |
|---|---|---|
| -17.12% | 170M | |
| -16.80% | 8.79B | |
| +67.50% | 4.19B | |
| -4.03% | 2.48B | |
| -42.54% | 2.29B | |
| -6.49% | 1.97B | |
| -20.45% | 1.56B | |
| -41.24% | 1.22B | |
| +10.26% | 1.13B | |
| +18.74% | 933M |
BIODESIX, INC. 